Total Payments
$12,835
2024 Payments
$3,016
Companies
49
Transactions
628
Medicare Patients
2,481
Medicare Billing
$589,056
Payment Breakdown by Category
Food & Beverage$12,677 (98.8%)
Education$133.78 (1.0%)
Other$24.26 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,677 | 621 | 98.8% |
| Education | $133.78 | 5 | 1.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $24.26 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $3,143 | 199 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,086 | 92 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $929.29 | 48 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $809.57 | 29 | $0 (2024) |
| United Therapeutics Corporation | $612.59 | 26 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $560.60 | 22 | $0 (2024) |
| GENZYME CORPORATION | $543.95 | 21 | $0 (2024) |
| Merck Sharp & Dohme LLC | $425.73 | 20 | $0 (2024) |
| Grifols USA, LLC | $393.12 | 22 | $0 (2024) |
| INTUITIVE SURGICAL, INC. | $367.77 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,016 | 129 | AstraZeneca Pharmaceuticals LP ($454.70) |
| 2023 | $2,252 | 108 | GlaxoSmithKline, LLC. ($562.99) |
| 2022 | $1,585 | 72 | GlaxoSmithKline, LLC. ($713.74) |
| 2021 | $871.58 | 39 | GlaxoSmithKline, LLC. ($207.43) |
| 2020 | $473.76 | 16 | Bayer HealthCare Pharmaceuticals Inc. ($138.61) |
| 2019 | $1,394 | 79 | GlaxoSmithKline, LLC. ($395.35) |
| 2018 | $1,545 | 94 | GlaxoSmithKline, LLC. ($376.27) |
| 2017 | $1,699 | 91 | GlaxoSmithKline, LLC. ($417.26) |
All Payment Transactions
628 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/21/2024 | Bayer Healthcare Pharmaceuticals Inc. | Adempas (Drug) | Food and Beverage | In-kind items and services | $22.01 | General |
| Category: Cardio-pulmonary | ||||||
| 12/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: RESPIRATORY | ||||||
| 12/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $1.89 | General |
| Category: RESPIRATORY | ||||||
| 12/17/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $135.00 | General |
| Category: SURGERY | ||||||
| 12/16/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $22.99 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $1.28 | General |
| Category: IMMUNOLOGY | ||||||
| 12/13/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $7.66 | General |
| Category: Inflammation | ||||||
| 12/12/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $24.62 | General |
| Category: Pulmonology | ||||||
| 12/11/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.09 | General |
| Category: Immunology | ||||||
| 11/28/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $15.69 | General |
| 11/15/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $9.66 | General |
| Category: Inflammation | ||||||
| 11/14/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $30.05 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 11/13/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $38.79 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/13/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: Respiratory | ||||||
| 11/11/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $27.68 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/07/2024 | Bayer Healthcare Pharmaceuticals Inc. | Adempas (Drug) | Food and Beverage | In-kind items and services | $149.95 | General |
| Category: Cardio-pulmonary | ||||||
| 11/07/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: RESPIRATORY | ||||||
| 11/07/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $2.88 | General |
| Category: RESPIRATORY | ||||||
| 11/06/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $33.19 | General |
| Category: Respiratory | ||||||
| 11/05/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: Respiratory | ||||||
| 11/05/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $7.49 | General |
| Category: Inflammation | ||||||
| 11/04/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $23.88 | General |
| Category: Cardiology | ||||||
| 10/31/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: RESPIRATORY | ||||||
| 10/30/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $41.47 | General |
| Category: Immunology | ||||||
| 10/29/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $1.12 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 642 | 1,179 | $546,095 | $134,267 |
| 2022 | 15 | 620 | 1,425 | $341,176 | $155,300 |
| 2021 | 15 | 606 | 1,403 | $258,153 | $154,140 |
| 2020 | 14 | 613 | 1,646 | $241,910 | $145,348 |
Total Patients
2,481
Total Services
5,653
Medicare Billing
$589,056
Procedure Codes
59
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 162 | 278 | $158,460 | $38,258 | 24.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 41 | 124 | $109,120 | $21,197 | 19.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 52 | 247 | $54,340 | $15,871 | 29.2% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2023 | 25 | 27 | $55,620 | $14,560 | 26.2% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 37 | 98 | $27,440 | $8,734 | 31.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 65 | 72 | $29,160 | $7,074 | 24.3% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2023 | 11 | 12 | $23,700 | $5,923 | 25.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 46 | 46 | $24,380 | $5,769 | 23.7% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 29 | 72 | $15,480 | $4,302 | 27.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 14 | 42 | $13,440 | $4,058 | 30.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 22 | 23 | $14,145 | $3,174 | 22.4% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 42 | 42 | $7,980 | $1,989 | 24.9% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 39 | 39 | $6,825 | $1,791 | 26.2% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 41 | 41 | $5,125 | $1,335 | 26.0% |
| 94664 | Evaluation of use of breathing device | Office | 2023 | 16 | 16 | $880.00 | $233.28 | 26.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 143 | 230 | $73,815 | $32,514 | 44.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 52 | 165 | $75,522 | $29,480 | 39.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 70 | 429 | $51,893 | $25,013 | 48.2% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2022 | 35 | 37 | $39,536 | $20,059 | 50.7% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 47 | 238 | $25,466 | $13,817 | 54.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 87 | 105 | $22,725 | $10,004 | 44.0% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2022 | 13 | 13 | $14,923 | $6,756 | 45.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 41 | 41 | $11,622 | $5,262 | 45.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 24 | 24 | $7,440 | $3,904 | 52.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 20 | 43 | $6,880 | $3,623 | 52.7% |
About Dr. Elbert Chang, MD
Dr. Elbert Chang, MD is a Pulmonary Disease healthcare provider based in Montclair, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1053417808.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Elbert Chang, MD has received a total of $12,835 in payments from pharmaceutical and medical device companies, with $3,016 received in 2024. These payments were reported across 628 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($12,677).
As a Medicare-enrolled provider, Chang has provided services to 2,481 Medicare beneficiaries, totaling 5,653 services with total Medicare billing of $589,056. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Montclair, CA
- Active Since 09/16/2006
- Last Updated 08/22/2023
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1053417808
Products in Payments
- TRELEGY ELLIPTA (Drug) $1,598
- DUPIXENT (Biological) $1,212
- NUCALA (Biological) $908.39
- Adempas (Drug) $809.57
- OFEV (Drug) $575.67
- TEZSPIRE (Biological) $540.39
- BREZTRI (Drug) $441.61
- FASENRA (Biological) $427.51
- ORENITRAM (Drug) $402.39
- Da Vinci Surgical System (Device) $367.77
- SYMBICORT (Drug) $354.57
- BEVESPI AEROSPHERE (Drug) $296.22
- ANORO (Drug) $265.51
- STIOLTO RESPIMAT (Drug) $246.74
- Prolastin-C Liquid (Biological) $232.41
- WINREVAIR (Biological) $218.91
- Prolastin-C (Biological) $160.71
- ELIQUIS (Drug) $144.53
- UPTRAVI (Drug) $139.12
- FASENRA (Drug) $132.43
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Montclair
Alan Klukowicz, Md, MD
Pulmonary Disease — Payments: $6,657
Pulmonary Disease $6,657
John Kim, Do, DO
Pulmonary Disease — Payments: $3,936
Pulmonary Disease $3,936
Gene Hong, Md, MD
Pulmonary Disease — Payments: $3,866
Pulmonary Disease $3,866
Shahram Khorrami, M.d, M.D
Pulmonary Disease — Payments: $3,795
Pulmonary Disease $3,795
Frank Hsu, Md, MD
Pulmonary Disease — Payments: $3,307
Pulmonary Disease $3,307
Dr. Rick Siriratsivawong, Md, MD
Pulmonary Disease — Payments: $2,385
Pulmonary Disease $2,385